The water extract obtained from the aerial parts of Sideritis euboea (Lamiaceae), which is known in Greece as 'mountain tea', was investigated by determining the in vitro effect of this extract on the IL-6, OPG and RANKL secretion by osteoblasts, three important molecules in osteoblast-osteoclast interplay. The results showed that this extract reduced significantly the secretion of IL-6 by KS-483 osteoblasts, while it also suppressed RANKL secretion, with both effects being dose-dependent and more potent at the higher concentrations tested (50, 100 μg/mL). We further determined the chemical profile of the extract by applying an analytical U-HPLC-DAD-ESI-MS/MS method using the high resolution hybrid LTQ-Orbitrap Discovery spectrometer. An ESI source in negative mode was employed. The analysis indicated that the water extract of S. euboea is rich in flavonoid glycosides, and phenylpropanoid glycosides.
Bone undergoes constant remodeling throughout life, repairing thus its structural damage and holding its integrity. Bone remodeling depends on the tightly integrated activity of two major cell types, osteoclasts, responsible for bone resorption, and osteoblasts, responsible for bone formation while disruption of the tight coupling between osteoblast and osteoclast proceeds towards the condition known as osteoporosis. Osteoclast formation, activation, and survival, known as osteoclastogenesis, require the interaction of receptor activators of nuclear kappaB (RANK) and RANK ligand (RANKL), a conserved member of the TNF receptor and TNF ligand families, respectively [1] . RANKL, a protein expressed on the osteoblast cell membrane, binds to RANK, a receptor located on the osteoclast membrane. Osteoprotegerin (OPG), a secreted member of the TNF receptor family, is produced by cells of the osteoblast lineage and by other cells in the marrow. Binding of RANKL and RANK can be prevented by OPG binding to RANKL. OPG thus acts as a decoy receptor in the RANK-RANKL signaling system inhibiting osteoclast formation. Thereby, osteoblasts play a direct and essential role in the osteoclastogenesis, which involves the regulation of osteoprotegerin/ RANKL/RANK axis [1] . Additionally to this axis, proinflammatory cytokines are stimulatory to bone resorption by increasing the activity and differentiation of osteoclasts. Among these cytokines that has drawn the most attention is IL-6. Spontaneous increase in the expression and secretion of this cytokine with estrogen deficiency was first noted several years ago in osteoblasts [2] .
Although there is a variety of already established pharmacological antiosteoporotic interventions [bisphosphonates, agents derived from parathyroid hormone, strontium ranelate, raloxifene (SERM), HRT (Hormone Replacement Therapy) and calcitonin], longterm acceptance and/or compliance of them is low due to more or less serious adverse effects [3] . Thus, the need to develop safer therapies alternative to those that already exist is being recognized. In the past decades, numerous scientific studies demonstrate the positive effect of plant extracts and/or natural derived compounds towards osteoporosis in vitro and in vivo [4] [5] [6] .
The Mediterranean flora, due to its high diversity and endemism, contains a wide variety of plants which have been shown to exert a variety of biological properties. Among them, the genus Sideritis (Lamiaceae) is gaining an increasing pharmacological interest. It encompasses about 150 species growing mainly in the Mediterranean basin [7] . Different species of this genus are widely used in folk medicine in Europe and especially in Mediterranean countries due to their antiinflammatory, antioxidant, antirheumatic, antiulcer, digestive and antimicrobial properties [8] [9] [10] , mediated mostly by phenolic, terpenoid and flavonoid components [9, [11] [12] [13] . Specifically, in Greece, there are fifteen different taxa and S. euboea is a widely used species growing on the island of Evia (or Euboea) [14] . To our knowledge there is only one study referring to the antioxidant activity of various extracts of S. euboea and the identification of kaempferol as a major metabolite [11] .
As part of a continuing phytochemical investigation and biological evaluation of Mediterranean species of Sideritis, S. euboea was chosen for investigation. It has been demonstrated that the aqueous extract induced osteoblast differentiation, as evaluated by alkaline phosphatase activity, and mineralization of extracellular matrix, whilst suppressing the proliferation of breast cancer cells, without exhibiting proliferative effects on the uterus, data that support its SERM-like activity [15] .
Hence the aim of the present study was to investigate further the effects of the aqueous extract of S. euboea on IL-6, OPG and RANKL secretion by osteblasts and, in parallel, to develop a fast analytical method for the determination of the chemical profile of the extract using U-HPLC-DAD-MS/MS techniques. An important task of our study was to investigate the chemical composition of the tested sample, hence to understand the biological activities observed.
From a phytochemical point of view, the genus Sideritis is known for its high concentration of iridoids [16] , diterpenes [17] , flavonoid mono-, di-, and triglycosides, as well as for the occurrence of phenylpropanoid glycosides [10, 18] . To our knowledge, S. euboea, which is the basis of a widely used beverage in the Greek diet, has not been investigated phytochemically before. In order to characterize the identity of the constituents of the extract and possible candidate molecules for the effect on OPG, RANKL, IL-6 secretion by osteoblasts, a U-HPLC-DAD system was employed connected to a HRMS n spectrometer. Based on the retention time (t R ), the UV-Vis spectrum, the accurate mass measurements and the fragmentation pattern of the compounds revealed from the MS/MS, multiple information regarding the identity of the compounds was extracted. Specifically identified were three diglycosides of isoscutellarein, (6) and martinoside (7) , as well as one phenolic derivative of quinic acid, chlorogenic acid (8) . Figure 1 presents the U-HPLC-UV chromatogram of the extract measured at 280 nm. As clearly illustrated, most of the compounds, as well as the major ones, are eluted between 12 and 26 min. It should be noted that no specific treatment of the sample prior to analysis was carried out. Additionally, in Figure 2 , the total ion chromatogram (TIC) of the extract and the extracted ion chromatograms (XIC) of the identified compounds are presented. To the best of our knowledge, neither a U-HPLC nor a LC-MS profile of S. euboea has been previously reported. Furthermore, the identified compounds were studied according to their MS/MS. The main fragmentation pathways have been found to be associated with the loss of AcO, H 2 O, and hexose units for the acetylated flavonoid diglycosides ( Figure 3A ) and the loss of hexoses, H 2 O, Me and caffeic units for phenylpropanoid glycosides ( Figure  3B ). For chlorogenic acid, the main fragments were caffeic and quinic acid ( Figure 3C ).
Based on the accurate mass measurements, the RDB values and the fragmentation pattern established from the identified compounds, for both chemical categories, several other compounds could be proposed (compounds 9-15, Table 1 in supplementary data). The identification effort was focused in the investigation of the remaining major peaks except those which correspond to the standards. In this way the chemical content of the extract could be characterized. In Figure 4 , the extracted ion chromatograms for the proposed ions are presented.
The peak at 17.74 min, corresponding to compound 9, had a characteristic UV spectrum of flavonoid glycosides. The t R value was very close to those of the identified flavonoid diglycosides as well as the RDB value (13.5). The proposed molecular formula (C 28 Since RANKL, OPG, and IL-6 are among the key-players in the homeostatic mechanism of normal bone remodeling we tested the effects of the aqueous extract of S. euboea at final concentrations of 5, 10, 20, 50, and 100 g/mL, as well as 17-estradiol at a final concentration of 10 -7 and 10 -8 M, on the secretion of the above molecules. Estradiol reduced significantly IL-6 secretion by osteoblasts in both concentrations 10 -7 M and 10 -8 M compared with the control (untreated cells) (p < 0.01 and p < 0.05, respectively) ( Figure 5 ).
Aqueous extract of S. euboea reduced the secretion of IL-6 by osteoblasts in all tested concentrations, although the results were statistically significant only at higher concentrations of 100 g/mL (67% of control), 50 g/mL A)
B) C)
Effects of Sideritis euboea on IL-6, OPG and RANKL secretion Natural Product Communications Vol. 6 (11) 2011 1693 (79% of control), 20 g/mL (85% of control) (p < 0.01, p < 0.01, and p < 0.05, respectively) ( Figure 5 ). Treatment with ICI182780 (10 -8 M) in the presence of aqueous extract (100 μg/mL) partially abolished the effect of extract on the IL-6 secretion by osteoblasts. The difference in the effect between extract alone (100 μg/mL) and co-incubation with ICI182780 (10 -8 M) was marginally significant (p = 0.069), suggesting that mechanisms other than ER-mediation are possibly co-implicated. Figure 6 shows the effect of aqueous extract of S. euboea, as well as 17-estradiol on the secretion of OPG by osteoblasts. 17-Estradiol increased significantly the secretion of ΟPG by osteoblasts at both concentrations tested (10 -7 and 10 -8 M) with the lower concentration being more potent (121% and 136% of control, respectively). Aqueous extract of S. euboea induced marginally the secretion of OPG by osteoblasts, with the concentration of 50μg/mL showing the greater, but not statistically significant, effect (116% of control, p = 0.05). Treatment with ICI 182780 (10 -8 M) in the presence of aqueous extract (50 μg/mL) abolished any positive effect of the extract on the secretion of OPG, implicating a possible ER-mediated mechanism.
Finally, the effect of aqueous extract of S. euboea on the RANKL secretion by osteoblasts, as well as 17-estradiol is shown in Figure 7 . 17-Estradiol did not exert any significant effect on the secretion of RANKL at both the tested concentrations. On the contrary, extract of S. euboea decreased significantly the secretion of RANKL in almost all the higher concentrations tested. In particular, at concentrations of 100 and 50 g/mL, the reduction of RANKL secretion was 42% and 57% of the control, respectively (p < 0.01), while at concentrations of 20 and 5 g/mL it was 72% and 76% of control, respectively (p < 0.05).
Treatment with ICI182780 (10 -8 M) in the presence of aqueous extract (100 μg/mL) did not abolish the effect of the extract on the RANKL secretion by osteoblasts, suggesting that mechanisms other than ER-mediation are possibly implicated.
In our previous study [15] , by using KS483 cells, a mouse osteoblastic cell line which expresses both ERalpha (ER) and ERbeta (ER) [23] , we demonstrated that aqueous extract of S. euboea induced osteoblast differentiation and mineralization. In the present study, expanding our investigation, we evaluated for the first time a possible antiosteoclastogenic effect of the same S. euboea aqueous extract, on modulating the secretion of IL-6, OPG, and RANKL by osteoblasts. Given the known antiosteoclastogenic effect of estradiol, we used it as a positive control for our experiments. We found that estradiol decreased the secretion of basal levels of IL-6 in both concentrations tested ( Figure 5 ). Our results are in agreement with previous studies [24, 25] conducted in both which was similar to that of estradiol at both concentrations tested.
In line with previous reports [26, 27] , we found that estradiol induced significantly OPG secretion by 1694 Natural Product Communications Vol. 6 (11) 2011 Kassi et al. osteoblasts, while S. euboea extract did not show any significant effect at any of the concentrations tested; it is plausible that our findings may be due to differential activation of ER subtypes by estradiol and S.euboea aqueous extract's active constituents. It should be mentioned that, according to other in vitro studies, estradiol did not affect or even reduce the secretion of OPG by osteoblasts at the same concentrations [25] . The differential ER/ER content in the various osteoblast cell lines used could explain these discrepancies, since the two types of estrogen receptor have been shown to regulate differently the expression of OPG gene [27] . The effect of estradiol on the secretion of RANKL by KS483 was not significant, in contrast with S. euboea extract, which reduced significantly RANKL secretion at almost all tested concentrations. Previous studies have demonstrated that estradiol did not influence the expression of RANKL, neither mRNA nor its protein levels [24, 28] . On the contrary, Lindberg et al. [29] noticed an increase in RANKL mRNA.
Testing the aqueous extract of S. euboea (mountain tea), we saw that it reduced efficiently the secretion of IL-6 by KS-483 osteoblasts, while it also suppressed RANKL secretion, with both effects being dose-dependent and more potent at the higher concentrations tested (100 and 50 g/mL). It should be mentioned that the major effect of S. euboea on the osteoblastic differentiation and mineralization has been displayed at similar concentrations (50 and 25 g/mL) [15] .
Plant extracts have been studied on purpose to evaluate in vitro their antiosteoclastogenic activity via modulating IL-6, RANKL, and OPG secretion and found to be potent at similar concentrations [30, 31] , thereby the majority of the literature pertains to isolated plant-derived constituents.
Interestingly, a recent study by Yoon et al. [32] showed that isoscutellarein 5-O--D-glucopyranoside, when added in a concentration range of 0.1-1 g/mL to co-cultures between bone marrow cells and calvaria-derived osteoblastic cells, inhibited osteoclastogenesis, as evaluated by the number of tartrate-resistant acid phosphatase-positive multinucleated osteoclasts. However, the mechanism has not been defined. In line with our results, recent studies have shown that flavonoids, like catechin, apigenin, genistein, and daidzein, suppressed IL-6 production, by acting through estrogen receptors (alpha/beta) pathway or ER-independently [33, 34] . Although in vitro as well as clinical studies have demonstrated favorable effects of flavonoids like genistein, daidzein, and kaempferol on OPG secretion by osteoblasts [34] [35] [36] , in our study this effect has only marginally been shown. Different flavonoid constituents of our extract, as well as co-existence of flavonoids with sugars or the existence of other unknown compounds, which may exert a negative effect on OPG secretion [35] , could be offered as possible explanations.
Martynoside, a phenylethanoid glycoside, can bind to ER and ER exerting estrogenic/antiestrogenic effects, has been shown to enhance osteoblastic differentiation through the ER-mediated mechanism [37] , while, regarding a possible antiosteoclastogenic action, no studies exist. Chlorogenic acid has been shown to inhibit IL-6 production by human blood mononuclear cells [38] .
The differential effects between E 2 and S. euboea aqueous extract on regulation of gene transcription may be attributed to the presence of multiple compounds in the plant extract which may have a synergistic/additive effect, making the evaluation of the effectiveness of the plant extract rather than isolated compounds, more clinically significant.
In conclusion, our study a) provides, for the first time, data on the chemical composition of S. euboea b) extends existing data regarding the antiosteoporotic effects of S. euboea aqueous extract, c) provides new insights into understanding the molecular mechanism underlying the beneficial effects of S. euboea aqueous extract on osteoblast-osteoclast interplay.
Experimental

Plant material:
The flowering aerial parts of S. euboea (Lamiacae) were collected (2005) at Mt Dirfy of the island Evia (Greece). After being identified by Dr Eleutherios Kalpouzakis, a voucher specimen (no. Eb009) was deposited in the herbarium of Department of Pharmacy, University of Athens.
Preparation of extracts and samples:
The aerial parts of S. euboea (450 g) were air dried at room temperature, pulverized and extracted with distilled water. The resulting water extract was taken to dryness under vacuum and the weight of the residue was found to be 4.5 g. Three different sample concentrations of the extract 2.0, 5.0, and 10.0 mg in 1.0 mL 50% MeOH and two different sample concentrations of the isolated compounds, 0.5 and 1.0 mg/mL in 50% MeOH were prepared for UHPLC-DAD-MS/MS analysis. Both types of sample were filtered through a 0.45 m nylon filter prior to the analysis.
U-HPLC-DAD-ESI-MS/MS apparatus and conditions:
An ultra-HPLC system was employed for the phytochemical investigation of the extract and specifically an Accela LC system (ThermoFinnigan, San Jose, USA) consisted of a U-HPLC pump, a degasser, an autosampler and a PDA detector. The U-HPLC-DAD system was hyphenated to the hybrid LTQ-Orbitrap Discovery spectrometer (ThermoFinnigan, San Jose, USA) for the MS/MS and HRMS analysis, respectively. The Orbital trap allowed mass resolution around 30,000 and mass measurement accuracy close to 2 ppm to be achieved. The MS system was equipped with an ESI ionization probe and the analysis was performed in negative mode. A Hypersil GOLD column (Thermo Scientific) (50 x 2.1 mm, 1.9 m) was used for the analysis. A fast gradient elution method Effects of Sideritis euboea on IL-6, OPG and RANKL secretion Natural Product Communications Vol. 6 (11) 2011 1695 was developed and applied. The mobile phase used consisted of 0.1% aqueous formic acid (solvent A) and methanol (solvent B), at a flow rate of 400 L/min, at room temperature. The elution conditions used were: initial A-B (95:5); in 10 min A-B (90:10); in 7 min A-B (85:15); in 6 min A-B (70:30); in 7 min A-B (45:55); in 8.5 min A-B (5:95); back to initial conditions in 0.5 min; and equilibration for 1 min. The chromatograms were recorded at 220, 280, and 365 nm by monitoring spectra within a wavelength range of 190-700 nm. Mass spectra were recorded in a range from m/z 160 to 2000. The ESI source was operated at a sheath gas flow of 15 arb, auxiliary gas flow of 6 arb, ion spray voltage of 3.5 kV and a capillary temperature of 300°C. For the MS/MS experiments the energy level for CID was kept at 45%. For all the high accurate m/z measurements the mass tolerance was set to 5 ppm. Measurements outside that range were rejected. Kaempferol (MW: 286.0471) and rutin (MW: 610.1528) were used as internal standards. Identification of compounds was accomplished by comparing the retention time (t R ), UV-Vis spectrum, high resolution MS, and MS/MS spectra of the peaks in the sample to those of standard compounds. Xcalibur 2.0.7 SP1 software was used for the organization and management of the data.
Cell culture of KS483 osteoblastic cell line: The KS483
cell line is a non-transformed stable subclone of a parental cell line KS4 that undergoes in vitro osteoblast differentiation in association with formation of a bone-like mineralized extracellular matrix. The KS483 cells were grown in α-minimum essential medium (-MEM, Gibco-BRL) supplemented with 10% fetal bovine serum (Gibco-BRL) and penicillin/streptomycin (Gibco-BRL) in a CO 2 incubator (5% CO 2 -95% air) at 37°C and subcultured every 3-4 days at a dilutionof 1:5 to 1:6 using trypsin 0.125%/EDTA 0.01% solution.
For our experiments, the KS483 cells were seeded in 12well plates (at a density of 45,000 cells per well) in phenol red-free MEM supplemented with 10% FBS, dextran-coated charcoal slurry-treated (DCC-treated). Two days after plating, medium was refreshed and aqueous plant extract was added at 5 different concentrations (100, 50, 20, 10, 5, and 0 g/mL). 17-Estradiol was also used as positive control at 2 different concentrations (10 -7 -10 -8 M). Treatment with ICI 182780 (10 -8 M), which is a complete ER antagonist, in the presence of aqueous extract was also performed. Time course experiment was carried out (data not shown) in order to decide the incubation time. Forty-eight h after the addition of test plant extract, the supernatants were collected, centrifuged to remove particulates, and stored at -80°C in aliquots until assayed for IL-6, OPG, and RANKL.
IL-6, OPG and RANKL measurement:
IL-6 was measured by a quantitative sandwich enzyme immunoassay technique (Quantikine mouse IL-6 immunoassay, R&D Systems, Minneapolis MN, USA). OPG and RANKL were measured by ELISA technique (mouse OPG/TNFRSF11B, and Quantikine mouse RANKL immunoassay, respectively, R&D Systems, Minneapolis MN, USA) according to the instruction manual. All values are expressed as the mean ± standard deviation of 4 measurements. Statistical analysis was performed using t-test, two-tailed distribution assuming two-sample unequal variance. A p < 0.05 value was considered statistically significant (* p < 0.05, ** p < 0.01, *** p < 0.005).
